Acrivastine

Suppliers

Names

[ Name ]:
Acrivastine

[Synonym ]:
2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-
Semprex
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
(E)-6-[(E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl]-2-pyridineacrylic Acid
Acrivastine
BW 270C
Acrivastinum
BW A825C
Acrivastina
(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid
(2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}acrylic acid
MFCD00869830
Acrivastin
Duact
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid
2-propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]-2-pyridinyl]-, (2E)-
BW 825C

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
555.1±50.0 °C at 760 mmHg

[ Melting Point ]:
55.5-59.5 °C(lit.)

[ Molecular Formula ]:
C₂₂H₂₄N₂O₂

[ Molecular Weight ]:
348.438

[ Flash Point ]:
289.5±30.1 °C

[ Exact Mass ]:
348.183777

[ PSA ]:
53.43000

[ LogP ]:
4.55

[ Vapour Pressure ]:
0.0±1.6 mmHg at 25°C

[ Index of Refraction ]:
1.627

[ Storage condition ]:
2-8°C

MSDS

Click to get detail MSDS

Safety Information

[ Hazard Codes ]:
Xn,Xi

[ Risk Phrases ]:
R22:Harmful if swallowed. R43:May cause sensitization by skin contact.

[ Safety Phrases ]:
S37/39

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
UD3474000

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

2,6-Dibromopyridine
6-BROMO-2-PYRIDYL P-TOLYL KETONE
2-bromo-6-[2-(p-tolyl)-1,3-dioxolan-2-yl]pyridine

DownStream

Articles

Identification of novel functional inhibitors of acid sphingomyelinase.

PLoS ONE 6 , e23852, (2011)

We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid Sphing...

Simultaneous analysis of the H1-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride by high-performance liquid chromatography.

J. Pharm. Biomed. Anal. 37(4) , 663-7, (2005)

High-performance liquid chromatography (HPLC) was used for the simultaneous quantification of the H(1)-antihistamine acrivastine and the decongestant pseudoephedrine hydrochloride. Both compounds were...

Onset-of-action for antihistamine and decongestant combinations during an outdoor challenge.

Ann. Allergy Asthma Immunol. 84(4) , 451-9, (2000)

Medications containing a combination antihistamine-decongestant are commonly used for allergic rhinitis yet onset-of-action comparisons for symptom relief after a single dose have not been performed.T...

Acrivastine D7
Acrivastine / pseudoephedrine
Acrivastine and pseudoephedrine
Acrivastine Impurity 1（Acrivastine 2,3-Dihydro Impurity）
6-Chloro-5-(difluoromethyl)-3-(hydroxymethyl)pyridin-2-ol
2-(6-Bromo-4-(difluoromethyl)-5-hydroxypyridin-3-yl)acetonitrile
3-(Difluoromethyl)-4-(hydroxymethyl)-6-iodopicolinonitrile
2-(6-Chloro-5-(difluoromethyl)pyridin-3-yl)acetic acid
3-(Aminomethyl)-5-(difluoromethyl)-6-methylpyridin-2-amine
6-(Difluoromethyl)-3-fluoro-5-methylpicolinonitrile
2,5-Dibromo-3-(difluoromethoxy)pyridine
2,6-Dichloro-4-(difluoromethoxy)benzodifluoride
2-Chloro-6-(difluoromethyl)-4-(trifluoromethyl)pyridine
(2,3-Dibromo-4-(difluoromethoxy)phenyl)methanol

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.